NEW YORK (GenomeWeb News) – Ventana Medical Systems and Syndax Pharmaceuticals have signed an agreement for the development of a companion diagnostic for a drug being developed by Syndax to treat non-small cell lung cancer patients.
NEW YORK (GenomeWeb News) – Ventana Medical Systems and Syndax Pharmaceuticals have signed an agreement for the development of a companion diagnostic for a drug being developed by Syndax to treat non-small cell lung cancer patients.